Clipbook | $3,300,000 | (Dec 2, 2025)
Jeeva AI | $9,000,000 | (Dec 2, 2025)
Nevis | $35,000,000 | (Dec 2, 2025)
Certified by Founder
Lodge
Congruence Therapeutics
start up
Canada
- Montreal, Quebec
- 07/03/2023
- Series A
- $65,000,000
Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir, sees proteins in ways others have been unable to see - in their full dynamic state.
- Industry Biotechnology Research
- Website https://congruencetx.com/
- LinkedIn https://www.linkedin.com/company/congruencetx/people/
Related People
Clarissa DesjardinsFounder
Canada -
Montreal, Quebec,
Experienced biotechnology executive and founder of three successful biotechnology companies. Founded Clementia Pharmaceuticals and led it to Phase 3 human clinical trials for fibrodysplasia ossificans progressiva (FOP), a disease of abnormal new bone formation, until its acquisition by Ipsen for $1.3 billion dollars in 2019.
Raindrop | $15,000,000 | (Dec 2, 2025)
Mixx Technologies Inc | $33,000,000 | (Dec 2, 2025)
Onton | $7,500,000 | (Dec 2, 2025)
Sokin | $50,000,000 | (Dec 2, 2025)
Tutor | $34,000,000 | (Dec 2, 2025)
Black Forest Labs | $300,000,000 | (Dec 2, 2025)
Marble Imaging | $6,152,690 | (Dec 2, 2025)
Global Work AI | $2,400,000 | (Nov 27, 2025)
Procure Ai | $13,000,000 | (Nov 27, 2025)